Review





Similar Products

97
TaKaRa anti brevican mouse monoclonal antibody
Anti Brevican Mouse Monoclonal Antibody, supplied by TaKaRa, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brevican/Living+Colors+DsRed+Polyclonal+Antibody/pm41430471-809-53-68
Average 97 stars, based on 1 article reviews
anti brevican mouse monoclonal antibody - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

94
R&D Systems recombinant bcan
( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 <t>(BCAN</t> + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .
Recombinant Bcan, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brevican/Recombinant+Mouse+Brevican+Protein%2C+CF/bio_rxiv__64898__2026__03__26__713760-254-27-31
Average 94 stars, based on 1 article reviews
recombinant bcan - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

94
R&D Systems recombinant human brevican
( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 <t>(BCAN</t> + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .
Recombinant Human Brevican, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brevican/Recombinant+Human+Brevican+Protein%2C+CF/pm41711854-38-0-6
Average 94 stars, based on 1 article reviews
recombinant human brevican - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

93
R&D Systems sheep anti brevican
( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 <t>(BCAN</t> + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .
Sheep Anti Brevican, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brevican/Human%2FRat+Brevican+Antibody/pm41707919-72-24-26
Average 93 stars, based on 1 article reviews
sheep anti brevican - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Addgene inc si10 brevican
( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 <t>(BCAN</t> + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .
Si10 Brevican, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brevican/SI10-Brevican+(Plasmid+%2346300)/pm41430471-388-4-5
Average 93 stars, based on 1 article reviews
si10 brevican - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

97
TaKaRa mouse anti brevican
( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 <t>(BCAN</t> + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .
Mouse Anti Brevican, supplied by TaKaRa, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brevican/Living+Colors+DsRed+Polyclonal+Antibody/pm41430471-387-10-16
Average 97 stars, based on 1 article reviews
mouse anti brevican - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

93
Novus Biologicals rabbit anti brevican
( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 <t>(BCAN</t> + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .
Rabbit Anti Brevican, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/brevican/Brevican+Antibody/pm41366031-323-61-65
Average 93 stars, based on 1 article reviews
rabbit anti brevican - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

Image Search Results


( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 (BCAN + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .

Journal: bioRxiv

Article Title: Spike-in probe-enhanced single-cell RNA-seq reveals post-infusion transcriptomic remodeling of “prime-and-kill” synNotch-CAR-T cells

doi: 10.64898/2026.03.26.713760

Figure Lengend Snippet: ( A–C ) Histograms and empirical cumulative distribution function (ECDF) plots showing distribution of maxUMI CAR values in in vitro E-SYNC cells ( A ), in vitro B-SYNC cells ( B ), and in vivo samples ( C ). In the histograms, the bin width is 1, and the Y-axis is shown on a log 10 scale. In both histograms and ECDF plots, maxUMI CAR values >50 were capped at 50 for visualization. (D) Dot plot showing expression of representative DEGs by sample type (same gene list as in and ), stratified by CAR-expressing versus non-expressing groups. (E) Swarm plot and ECDF plot depicting the distribution of TRM core gene signature scores. Differences between CAR-positive and -negative cells within the brain were assessed using the Kolmogorov–Smirnov test ( P = 4.0 × 10 -5 ). (F) ECDF plots comparing the nCount_RNA and nFeature_RNA values between CAR-expressing and non-expressing cells within the brain-derived CD8 + synNotch-positive population. Differences were assessed using the Kolmogorov–Smirnov test. (G) Schematic overview of the time-course co-culture experiment of B-SYNC cells with the human GBM cell line GBM6 (BCAN + /EphA2 + /IL13Rɑ2 + ). Co-culture was performed using 24-well plates, with each well containing 0.5 × 10 5 GBM cells and 1 × 10 6 CD8 + B-SYNC cells. The data presented are representative of two independent experiments using different donors. Additional data are shown in Fig. S16 . (H) Flow cytometry analysis showing the percentage of cells expressing GFP fused to CAR within the live, singlet, non-tumor (mCherry-negative) population. Corresponding scatter plots are shown in Fig. S16 . (I) RT-qPCR data showing CAR transcript abundance across conditions. Relative expression was calculated using the 2 -ΔΔCq method, with the B-SYNC no-stimulation (no-stim) condition and the RPS18 transcript as references. ( J–K ) Bulk RNA-seq principal component analysis (PCA) plot ( J ) and gene expression heatmap ( K ) illustrating transcriptomic similarities and differences across samples. The heatmap displays scaled expression of 6,885 genes expressed in the B-SYNC no-stim sample at transcripts-per-million (TPM) ≥ 10, sorted by the magnitude of expression changes between no-stim and post-stimulation conditions. ( L ) Representative genes minimally expressed without co-culture but upregulated and sustained after co-culture. The full list of gene expression comparisons is provided in Supplementary Table S13 .

Article Snippet: To prepare the B-SYNC primed sample, 2 × 10 4 cells were cultured for 24 hours on wells coated with Laminin (100 μg/ml, Thermo Fisher Scientific,23017015) and recombinant BCAN (25 μg/ml; R&D Systems, 7188-BC-050 and 4009-BC-050).

Techniques: In Vitro, In Vivo, Expressing, Derivative Assay, Co-Culture Assay, Flow Cytometry, Quantitative RT-PCR, RNA Sequencing, Gene Expression